Remotely Monitored and Coached Cardiac Rehabilitation Northern Sweden (RECREATION)

May 11, 2023 updated by: Camilla Sandberg, Umeå University

Remotely Monitored and Coached Exercise Based Cardiac Rehabilitation in Northern Sweden l

Supervised exercise is an essential component of contemporary center-based cardiac rehabilitation (CR) programs. Despite the proven effectiveness, uptake and adherence to supervised exercise-based CR (exCR) remains suboptimal (approximately 50%), especially in rural and remote areas of Sweden. The main reasons for low participation rate in centre-based exCR are different accessibility barriers i.e. long distances, transportation problems or employment commitments. In this randomised clinical trial, the overall aim is to evaluate the effectiveness of, home-based, remotely monitored and coached exCR using the REMOTE-CR system compared to home-based exCR based on individualized information regarding current exercise recommendations but without monitoring and coaching (usual care) to improve exercise capacity. Our hypothesis is that remotely monitored and coached exCR will improve exercise capacity to a greater extent than home-based exCR without monitoring and coaching (usual care).

Study Overview

Status

Recruiting

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Helena Cronesten, RPT
  • Phone Number: +46907858441

Study Locations

      • Umeå, Sweden
        • Recruiting
        • Umea University Hospital
        • Contact:
          • Helena Cronesten, RPT
          • Phone Number: +46907858441
        • Contact:
          • Camilla Sandberg, PhD
          • Phone Number: +46907858441

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Scheduled appointment with physiotherapist for follow-up after cardiac event: ----Myocardial Infarction (MI)
  • Per cutaneous coronary intervention (PCI) due to MI or angina pectoris
  • Open heart surgery due to coronary artery disease or valvar disease
  • Living in the catchment area of Heart centre, University Hospital of Umeå.

Exclusion Criteria:

  • Clinically unstable
  • Postoperative infection
  • Comorbidity affecting ability to participate in exCR

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: REMOTE-CR
Remotely monitored and coached exercise training in real time using the REMOTE-CR system. The patients randomized to remotely monitored exercise can either work out with self-selected activities e.g. Nordic-walking, cycling, skiing or participate in supervised exercise session via video link.
The patients randomized to remotely monitored exercise can either work out with self-selected activities e.g. Nordic-walking, cycling, skiing or participate in supervised exercise session via video link. Remotely monitored exercise training sessions will be offered monday-friday 13.00-16.00.
Other: Usual care
The patients randomized to be controls will receive individualized information and instructions regarding current exercise recommendations but will not be monitored or coached during their exercise sessions (usual care).
The patients randomized to be controls will receive individualized information and instructions regarding current exercise recommendations but will not be monitored or coached during their exercise sessions (usual care)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in submaximal aerobic exercise capacity
Time Frame: Baseline and 12 weeks
The aerobic exercise capacity (W) will be evaluated using a standardised submaximal exercise test on cycle ergometer
Baseline and 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle endurance capacity
Time Frame: Baseline and 12 weeks
Number of repetitions achieved during test of Unilateral isotonic shoulder flexion and Unilateral isotonic heel-lift
Baseline and 12 weeks
Isometric grip strength
Time Frame: Baseline and 12 weeks
Isometric grip strength will be evaluated using a hydraulic hand dynamometer
Baseline and 12 weeks
Self-reported physical activity using theInternational Physical Activity Questionnaire
Time Frame: Baseline and 12 weeks

International Physical Activity Questionnaire: Results will be presented as a continuous variable, total metabolic equivalent (MET) minutes per week, where a higher score indicates a higher physical activity level. Result will also be presented as a categorical variable:

High Physical activity level: achieving a total physical activity of at least 3000 MET-minutes/week.

Moderate physical activity: achieving a minimum of at least 600 MET-minutes per week.

Low physical activity level: not achieving the minimum of 600 MET minutes per week

Baseline and 12 weeks
Self-reported physical activity using the physical activity scale br Frändin and Grimby
Time Frame: Baseline and 12 weeks
The Activity scale by Frändin and Grimby describes 6 levels of physical activity. The scale includes 6 items that ranges from 1 indicating mostly physically inactive to 6 indicating a very high physical activity level.
Baseline and 12 weeks
Kinesiophobia (fear of movement)
Time Frame: Baseline and 12 weeks
The Swedish version of the Tampa scale for Kinesiophobia Heart (TSK-SV Heart) The scale comprises 17 items assessing subjective rating of kinesiophobia. The total score varies between 17-68 and a score >37 defines a high level of kinesofobia.
Baseline and 12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of change the participation rate in supervised cardiac rehabilitation
Time Frame: 12 weeks
Evaluation of change the participation rate can be enhanced using the REMOTE -CR system
12 weeks
Patients experiences of REMOTE-CR and and exercise led via video link
Time Frame: 12 weeks
The study participants experience of the REMOTE-CR system and exercise sessions via video link will be evaluated using a questionnaire
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Camilla Sandberg, PhD, Umeå University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 3, 2019

Primary Completion (Anticipated)

December 31, 2023

Study Completion (Anticipated)

February 28, 2024

Study Registration Dates

First Submitted

March 15, 2018

First Submitted That Met QC Criteria

March 26, 2018

First Posted (Actual)

March 27, 2018

Study Record Updates

Last Update Posted (Actual)

May 12, 2023

Last Update Submitted That Met QC Criteria

May 11, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Defects, Congenital

Clinical Trials on REMOTE-CR

Subscribe